Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 409-413, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warnick, G. R.
Right arrow Articles by Volke, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warnick, G. R.
Right arrow Articles by Volke, T. M.

Clinical Chemistry, Vol 35, 409-413, Copyright © 1989 by American Association for Clinical Chemistry

Standardization of a commercial (Boehringer Mannheim diagnostics) enzymic method for cholesterol

GR Warnick, M Spain, H Kloepfer and TM Volke
Department of Medicine, University of Washington, Seattle 98104.

The Laboratory Standardization Panel of the National Cholesterol Education Program recommends that cholesterol method accuracy ideally be within 3% of the true value determined by the Abell-Kendall Reference Method, a component of the National Reference System for Cholesterol. As one of the Abell-Kendall network laboratories established to facilitate cholesterol standardization, the approach we recommend for determining accuracy involves a comparison analysis on patients' specimens by the method in question and by the Abell-Kendall method. Use of fresh specimens precludes matrix interactions that may influence enzymic measurement. Using this approach, we assessed an enzymic method for cholesterol with two instruments (Boehringer Mannheim/Hitachi 717 and 737), with BMD reagent, controls, and calibrator. Fresh and frozen sera were analyzed with both instruments over three days. The Abell-Kendall method was used at the Northwest Lipid Research Center on frozen aliquots of the same sera. Both instruments demonstrated good agreement with the Reference Method, as determined by linear regression; overall bias averaged less than -2% for the Hitachi 717 and -1% for the Hitachi 737 at 2000 mg/L--i.e., within the accuracy recommendation. We observed a difference in bias for fresh and frozen specimens; with the Hitachi 717, fresh specimens exhibited -3% bias at 2000 mg/L, but there was virtually no bias of determinations of frozen specimens.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
G. R. Warnick, M. Nauck, and N. Rifai
Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays
Clin. Chem., September 1, 2001; 47(9): 1579 - 1596.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.